Phoenix Venture Partners II LP 4

Accession 0000899243-21-030340

CIK 0001672688other

View on SEC.gov Company Profile

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 4:11 PM ET

Size

42.6 KB

Accession

0000899243-21-030340

Insider Transaction Report

Form 4

Period: 2021-07-26

Absci CorpABSI

Phoenix Venture Partners II LP

10% Owner

Transactions

Conversion
Common Stock
2021-07-26+33,675→ 14,185,602 total
Conversion
Series C Preferred Stock
2021-07-26−82,689→ 0 total
→ Common Stock (273,130 underlying)
Conversion
Series E Preferred Stock
2021-07-26−10,195→ 0 total
→ Common Stock (33,675 underlying)
Conversion
Series A-4 Preferred Stock Warrant
2021-07-26−93,007→ 0 total
Exercise: $1.00Exp: 2026-09-29→ Series A-4 Preferred Stock (93,007 underlying)
Conversion
Common Stock Warrant
2021-07-26+307,211→ 0 total
Exercise: $1.00Exp: 2026-09-29→ Common Stock (307,211 underlying)
Conversion
Common Stock
2021-07-26+5,681,332→ 5,681,332 total
Conversion
Common Stock
2021-07-26+533,735→ 6,215,067 total
Conversion
Common Stock
2021-07-26+4,954,650→ 11,169,717 total
Conversion
Common Stock
2021-07-26+2,590,991→ 13,760,708 total
Conversion
Common Stock
2021-07-26+273,130→ 14,033,838 total
Conversion
Common Stock
2021-07-26+84,348→ 14,118,186 total
Conversion
Common Stock
2021-07-26+33,741→ 14,151,927 total
Conversion
Series A-1 Preferred Stock
2021-07-26−1,720,000→ 0 total
→ Common Stock (5,681,332 underlying)
Conversion
Series A-2 Preferred Stock
2021-07-26−161,586→ 0 total
→ Common Stock (533,735 underlying)
Conversion
Series A-3 Preferred Stock
2021-07-26−1,500,000→ 0 total
→ Common Stock (4,954,650 underlying)
Conversion
Series B Preferred Stock
2021-07-26−784,412→ 0 total
→ Common Stock (2,590,991 underlying)
Conversion
Series D-1 Preferred Stock
2021-07-26−25,536→ 0 total
→ Common Stock (84,348 underlying)
Conversion
Series D-2 Preferred Stock
2021-07-26−10,215→ 0 total
→ Common Stock (33,741 underlying)

Phoenix General Partner II LLC

10% Owner

Transactions

Conversion
Common Stock
2021-07-26+273,130→ 14,033,838 total
Conversion
Series A-1 Preferred Stock
2021-07-26−1,720,000→ 0 total
→ Common Stock (5,681,332 underlying)
Conversion
Series B Preferred Stock
2021-07-26−784,412→ 0 total
→ Common Stock (2,590,991 underlying)
Conversion
Series D-2 Preferred Stock
2021-07-26−10,215→ 0 total
→ Common Stock (33,741 underlying)
Conversion
Common Stock
2021-07-26+84,348→ 14,118,186 total
Conversion
Common Stock
2021-07-26+33,741→ 14,151,927 total
Conversion
Common Stock
2021-07-26+533,735→ 6,215,067 total
Conversion
Common Stock
2021-07-26+4,954,650→ 11,169,717 total
Conversion
Series D-1 Preferred Stock
2021-07-26−25,536→ 0 total
→ Common Stock (84,348 underlying)
Conversion
Common Stock
2021-07-26+5,681,332→ 5,681,332 total
Conversion
Common Stock
2021-07-26+2,590,991→ 13,760,708 total
Conversion
Series A-3 Preferred Stock
2021-07-26−1,500,000→ 0 total
→ Common Stock (4,954,650 underlying)
Conversion
Series C Preferred Stock
2021-07-26−82,689→ 0 total
→ Common Stock (273,130 underlying)
Conversion
Series E Preferred Stock
2021-07-26−10,195→ 0 total
→ Common Stock (33,675 underlying)
Conversion
Series A-4 Preferred Stock Warrant
2021-07-26−93,007→ 0 total
Exercise: $1.00Exp: 2026-09-29→ Series A-4 Preferred Stock (93,007 underlying)
Conversion
Series A-2 Preferred Stock
2021-07-26−161,586→ 0 total
→ Common Stock (533,735 underlying)
Conversion
Common Stock Warrant
2021-07-26+307,211→ 0 total
Exercise: $1.00Exp: 2026-09-29→ Common Stock (307,211 underlying)
Conversion
Common Stock
2021-07-26+33,675→ 14,185,602 total

Footnotes (12)

[F1]The Series A-1 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F10]The Series E Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F11]Prior to July 26, 2021, these warrants were exercisable by the holder at its option for shares of the Issuer's Series A-4 Preferred Stock at an exercise price of $1.00 per share any time prior to their expiration date.
[F12]The warrant for 93,007 shares of Series A-4 Preferred Stock converted into a warrant for 307,211 shares of Common Stock upon the one-for-3.3031 reverse split.
[F2]Reflects one-for-3.3031 stock split which became effective on July 26, 2021.
[F3]Phoenix General Partner II LLC, as the sole general partner of Phoenix Venture Partners II LP, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
[F4]The Series A-2 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F5]The Series A-3 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F6]The Series B Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F7]The Series C Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F8]The Series D-1 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.
[F9]The Series D-2 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Absci Corp

CIK 0001672688

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001647900

Filing Metadata

Form type: 4
Filed: Jul 27, 8:00 PM ET
Accepted: Jul 28, 4:11 PM ET
Size: 42.6 KB

View on SEC.gov